ORCID (Optional)

Twohig: https://orcid.org/0000-0002-5423-8749

Schober: https://orcid.org/0000-0002-5686-0312

McCashland: https://orcid.org/0000-0002-9659-272X

Peeraphatdit: https://orcid.org/0000-0001-7254-5016

Document Type



Community Health and Preventive Medicine | Digestive System Diseases | Higher Education | Male Urogenital Diseases | Medicine and Health Sciences


Prostate cancer screening is a controversial topic in the general population and is even more contested among liver transplant candidates. Not only should transplant programs be concerned about the risk of false positive screening results but also the competing risks of death and the diagnostic and therapeutic effects of true prostate cancer, which often does not cause significant morbidity or mortality in organ transplant recipients. Our letter highlights a best-practices approach to prostate cancer screening in transplant candidates using available research and consensus guidelines.




Prostate cancer; liver transplantation; screening

Creative Commons License

Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.